Hepatitis: Chronic HCV infection, diabetes and liver-related outcomes

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 9, 2014, Pages 520-521

  Henry, Linda ^a   Younossi, Zobair ^b  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; RIBAVIRIN;

ACUTE KIDNEY FAILURE; AGE DISTRIBUTION; ASCITES; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MIXED INFECTION; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; NOTE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL; TRANSPLANTATION FREE SURVIVAL;

DIABETES COMPLICATIONS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE;

EID: 84906874689     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro2014122     Document Type: Note

References (10)

1. Elkrief, L. et al. Diabetes mellitus is an independent prognostic factor for major liver related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology http://dx.doi.org/10.1002/hep.27228 (2014).
2. Stepanova, M., Lam, B., Younossi, Y., Srishord, M. K. & Younossi, Z. M. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity. J. Viral Hepat. 19, 341-345 (2012).
3. Younossi, Z. M., Stepanova, M., Nader, F., Younossi, Z. & Elsheikh, E. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment. Pharmacol. Ther. 37, 647-652 (2013).
4. Kiran, Z. et al. Insulin resistance in non-diabetic patients of chronic Hepatitis C. Pak. J. Med. Sci. 29, 201-204 (2013).
5. Miyajima, I. et al. Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: A population-based study in an HCV hyperendemic area. J. Gastroenterol. 48, 93-100 (2013).
6. Arase, Y. et al. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology 49, 739-744 (2009).
7. Aghemo, A. et al. Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C. Hepatology 56, 1681-1687 (2012).
8. Kawaguchi, Y. & Mizuta, T. Interaction between hepatitis C virus and metabolic factors. World J. Gastroenterol. 20, 2888-2901 (2014).
9. Moucari, R. et al. Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C. Gut 59, 1694-1698 (2010).
10. Sersté, T. et al. Metabolic disorders associated with chronic hepatitis C: impact of genotype and ethnicity. Liver Int. 30, 1131-1136 (2010).